Earum Pharmaceuticals Ltd. markets, trades, and distributes pharmaceutical formulation products. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2019-07-04. The firm is primarily engaged in marketing, trading and distribution of range of pharmaceutical formulation products, such as antibiotic drugs, antimalarial drugs, anti-allergic and anti-cold drugs, analgesic/anti-pyretic and anti-inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastrointestinal drugs, steroids, gynecology drugs, calcium, multivitamins, antioxidants and injections. The company offers a range of pharmaceutical formulation products, of which around 120 products are marketed by the Company under its own brand name. The firm also deals in the trading of active pharmaceutical ingredients (API’s). The company carries out distribution of a range of its business operations in domestic and international markets.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.
13 fields couldn't be derived. The company was scraped before the cash-flow and balance-sheet rows were captured. Re-running an analysis will refresh these.